GLSEF yields 51.67% · PFE yields 6.13%● Live data
📍 GLSEF pulled ahead of the other in Year 1
Combined, GLSEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLSEF + PFE for your $10,000?
Glorious Sun Enterprises Limited, an investment holding company, engages in interior decoration and renovation business in Mainland China, Hong Kong, Australia, New Zealand, Canada, the United States, and internationally. It operates through four segments: Interior Decoration and Renovation; Retail, Franchise and Others; Export Operations; and Financial Investments. The Interior Decoration and Renovation segment engages in the interior decoration and renovation businesses, as well as sale of furniture. The Retail, Franchise and Others segment engages in the retail operation in Hong Kong, as well as franchise sale activities under the Jeanswest brand in casual wear and apparel domain. The Export Operations segment exports apparel. The Financial Investments segment is involved in the treasury management and consulting business. The company also engages in the provision garment design, asset management, and agency services; and property development and management activities. In addition, it offers IT services comprising software products, software customization services, IT infrastructure construction, and IT operation and maintenance services; and logistics services, such as bonded warehouse, warehouse, trade declaration, processing trade, general trade, custom consultancy, shipping agency, loading and unloading, import and export of technology, system software development and technical support, inspection and quarantine, import and export agency, etc. Glorious Sun Enterprises Limited was founded in 1974 and is headquartered in Kowloon Bay, Hong Kong.
Full GLSEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.